Best Practices Guidelines
Accessed: 06.11.2019
ПРактИЧеское РукоВодстВо для соВместных меРоПРИятИй.
Constituting the fourth part of the World Drug Report 2022, this booklet focuses on the market dynamics of various stimulants – cocaine, amphetamines and “ecstasy” – and of NPS.
The first chapter contains an analysis of the global market for cocaine, starting with a review of cocaine supply..., including trends in the cultivation of coca bush and in the manufacture of and trafficking in cocaine at the global level and in the various regions. An analysis of different eradication strategies is included, as well as of the role of women in the cocaine supply chain. The chapter also presents the latest estimates of and trends in cocaine use, including a brief introduction to the various cocaine consumer products. Finally, it reviews the trends in the use of cocaine and the impact of the coronavirus disease (COVID-19) pandemic in different regions
more
Consolidated Guidelines
Geneva, 2016
The End TB Strategy
Report by the Director-General. 75th World health assembly 25 April 2022
How WHO works to prevent drug use, reduce harm and improve safe access to medicines
Putting Asia’s HIV response back on track
UNAIDS/10.03E / JC1767E (English original, March 2010) ISBN 978 92 9 173849 6
Science / People / Progress
Accessed: 12.11.2019
WHO working group on HIV incidence assays meeting report
10–11 December 2015
Glion, Switzerland
UNAIDS/WHO working group on global HIV/AIDS and STI surveillance
WHO/HIV/2017.03
Information Note
Advice for countries using or planning
to introduce dual HIV/syphilis RDT in antenatal services and other testing sites.
WHO/RHR/17.01
PLOS ONE | https://doi.org/10.1371/journal.pone.0192765 February 23, 2018
HIV-related advocacy evaluation training for civil society organisations